1. Medtech Insight
  3. >>R&D

Starts & Stops: Medtronic's Symplicity Flatlines For Heart Failure

 
• By Tina Tan

Starts & Stops is a regular feature highlighting Medtech Insight editors' picks of noteworthy medtech clinical trial initiations, completions and suspensions over the last month. This edition, which looks at trial updates from Sept. 8 through to Oct. 7, throws the spotlight on four studies that had the plug pulled, including Medtronic's Symplicity-HF trial.

Clinical Trial
Medtech Insight's round-up of clinical trial initiations and completions • Source: shutterstock.com

[Editor's note: This article was updated on Oct 10, 2016, to include more information on Symplicity-HF's one-year follow-up results and additional comments from the company in paragraphs 3, 6 and 7]

Symplicity-HF, the study of Medtronic PLC 's catheter-based renal denervation technology in patients with chronic heart failure and renal impairment, is among four trials that were terminated in the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from R&D

More from Business